Market Cap (In USD)
87.92 Million
Revenue (In USD)
42.16 Million
Net Income (In USD)
-14.38 Million
Avg. Volume
24.95 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.63-8.17
- PE
- -
- EPS
- -
- Beta Value
- 0.585
- ISIN
- US52634L1089
- CUSIP
- 52634L108
- CIK
- 1320350
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Nicholas T. Curtis
- Employee Count
- -
- Website
- https://www.lensar.com
- Ipo Date
- 2020-10-02
- Details
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
More Stocks
-
REPCOHOMERepco Home Finance Limited
REPCOHOME
-
1528
-
THLLYThales S.A.
THLLY
-
PGENYPigeon Corporation
PGENY
-
1193
-
DOID
-
WIMI
-
FLMTFFull Metal Minerals Ltd.
FLMTF